RobertStephenFishmanMD

Critical Care Medicine

Physician

Dr. Fishman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Massachusetts General Hospital/BIDMC/Harvard Medical SchoolFellowship, Pulmonary Disease and Critical Care Medicine, 1989 - 1992
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1986 - 1989
Stanford University School of MedicineClass of 1986

PubMed

134 citations
Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patient...
Steven D. Nathan, Carlo Albera, Williamson Z. Bradford, Ulrich Costabel, Roland M. du Bois
Thorax. 2016-05-01
92 citations
Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials
Lisa Lancaster, Carlo Albera, Williamson Z. Bradford, Ulrich Costabel, Roland M. du Bois
BMJ Open Respiratory Research. 2016-01-01
310 citations
Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials
Paul W. Noble, Carlo Albera, Williamson Z. Bradford, Ulrich Costabel, Roland M. du Bois
The European Respiratory Journal. 2016-01-01

First Patient Dosed in Trial of Aerosol-Delivered Genetic MedicineApril 6th, 2022
4D Molecular Therapeutics Reports Financial Results for the Year Ended December 31, 2020 and Provides Operational HighlightsMarch 25th, 2021